9105B |
Acetyl Fentanyl Screen, Blood |
9105SP |
Acetyl Fentanyl Screen, Serum/Plasma |
9105U |
Acetyl Fentanyl Screen, Urine |
9109B |
Atropine Screen, Blood |
9109SP |
Atropine Screen, Serum/Plasma |
9109U |
Atropine Screen, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9261B |
Scopolamine Screen, Blood |
9261SP |
Scopolamine Screen, Serum/Plasma |
9261U |
Scopolamine Screen, Urine |
9293B |
Methylenedioxymethamphetamine and Metabolite Screen, Blood |
9293SP |
Methylenedioxymethamphetamine and Metabolite Screen, Serum/Plasma |
9293U |
Methylenedioxymethamphetamine and Metabolite Screen, Urine |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9560B |
Synthetic Cannabinoids Screen, Blood |
9562U |
Synthetic Cannabinoid Metabolites Screen - Expanded, Urine |